DexCom Stock News & Updates
[WKN: A0D9T1 | Symbol: DXCM]
Dexcom: New Addressed Customer Segments, Margin Increase, and $1 Billion Share Buyback Shape Q3!
Sales in Q3 2026 increase by 11% year-on-year to $1.34 billion. The gross margin reaches 65.1%, a...
DexCom: Clinical Data Could Redefine the Market for Non-Insulin Type 2 Diabetics!
DexCom aims for a revenue of up to $5.25 billion for the entire year 2026. The CONNECT study demonstrates...
Pivotal Point Tracking DexCom (DXCM): Medical Technology Specialist Convinces with Q2 Figures - 13% Revenue Increase Thanks to Accurate Blood Sugar Monitoring
Dexcom is a medical technology specialist for continuous glucose monitoring systems. The devices enable...
A Chip Comeback Crowns One of the Most Dramatic Stock Market Months in Years and Saves Wall Street Into the Plus by Week’s End – Amazon Proves With Its Cloud Offensive That the AI Billions Pay Off, While Apple Stumbles Over Memory Shortages –The Fed Under Kevin Warsh Steers Toward a Hawkish September, Dollar and Long Bonds Come Under Pressure – After Forced Liquidations and a Historic Kospi Surge, DAX Brushes Against Record Highs, but the Ice Under the Recovery Remains Thin
USA & MACRO-ENVIRONMENT The Wall Street finds its way back to calmer waters after one of the most...
DexCom: 13% Revenue Growth in Q2 and the Effects of the CONNECT Study Data
DexCom focuses on continuous glucose monitoring systems and secures stable customer loyalty through...
Dexcom: Stelo Rollout and Record Margins Ignite Price Momentum
The successful introduction of the over-the-counter Stelo system opens up massive new patient groups...
Dexcom Inc.: The COO Sees the Long-Term Growth Potential of the Company - He Invests $1.0 Million!
Dexcom Inc. (DXCM) is a pioneer and leading company in the field of continuous glucose monitoring (CGM)...
Why DexCom's Bold Turn Represents an Opportunity
Sometimes, the best way to fix a mistake is to double down on it. That’s exactly what DexCom, the manufacturer...
DexCom: The Great Potential in the Diabetes Market
DexCom's decision to target the type 2 diabetes market was not flawed. The issue lay in the execution...
DexCom - Diabetes Care Specialist Impresses With Strong Market Position!
Business drivers: DexCom (DGX) The company is regarded as the provider of the industry’s most advanced...
TOP-5 Price Targets of Analysts on 02/03/25
DexCom [US2521311074]: Redburn Atlantic upgrades from "Neutral" to "Buy" and raises the price target...
- ‹
- 1
- ›